| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K02251932 |
| PharmacoGx | BRD-K02251932 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IGSF11 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | TRAPPC2 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | NELFA | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | TAF5L | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | NPIPA1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | LIMS4 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | WDR7 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | KCTD19 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | CYBA | CTRPv2 | pan-cancer | AAC | -0.081 | 0.07 |
| mRNA | FAM96B | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
